ACE2 – a rational frontline therapy for COVID 19
ACE2 – a rational frontline therapy for COVID 19
Lecture by world-leading geneticist Josef Penninger
March 12, 2020 | 17:00 CET
Free of charge
In spite of challenging times, the ESR remains committed to public health and the fight against the novel coronavirus disease.
Join us for a lecture by one of the world's leading geneticists and molecular immunologists, Prof. Josef Penninger. His lecture will shed light on the discovery and function of ACE2 (angiotensin converting enzyme 2) and its predisposition as a SARS-CoV and SARS-CoV-2 receptor.
The lecture will be free-of-charge and accessible to all.
